Insulin Receptor Insulin Receptor

Cat.No.	Name	Information
M54753	AVJ16	AVJ16 is a cancer cell migration inhibitor that targets the insulin-like growth factor 2 mRNA binding protein IGF2BP1 to inhibit the migration of H1299 cells with high endogenous IGF2BP1 expression.
M50422	S961	S961 is an high-affinity and selective insulin receptor (IR) antagonist with IC50s of 0.048, 0.027, and 630 nM for HIR-A, HIR-B, and human insulin-like growth factor I receptor (HIGF-IR) in SPA-assay, respectively.
M22472	Insulin degludec	Insulin degludec is an ultra-long-acting form of insulin, shows binding efficiency with an IC50 value of 19.59 nM/L for insulin receptor. Insulin degludec can be used for the research of type 1 and type 2 diabetes.
M11317	S961 TFA	S961 TFA is A high affinity insulin receptor (IR) antagonist with IC50 of 0.048 for HIR-A, HIR-B and higF-IR, respectively. 0.027 and 630 nM.
M6662	Demethylasterriquinone B1	Demethylasterriquinone B1 is a selective insulin RTK activator.
M4598	Rhoifolin	RhoifolinRhoifolin is a flavonoid glycoside isolated from the leaves of Guanxi pomelo (Citrus Grandis). Rhoifolin is beneficial to diabetic complications by enhancing adiponectin secretion, tyrosine phosphorylation of insulin receptor-β and translocation of GLUT4. Rhoifolin ameliorates titanium-stimulated osteolysis and attenuates osteoclast formation through ranKL-induced NF-κB and MAPK pathways.
M4100	Kaempferitrin	Kaempferitrin is a natural flavonoid glycoside with pain relief, anti-inflammatory, anti-diabetes, anti-tumor and other effects, and can activate insulin signaling.
M3734	KU14R	KU14R is a new I(3)-R antagonist that selectively blocks the insulin secretory response to imidazolines.
M54458	[D-Ala2]-GIP (human)	[D-Ala2]-GIP (human) is a GIP receptor agonist.
M54271	Gastric Inhibitory Peptide, porcine	Gastric Inhibitory Peptide, porcine is a glucose-dependent insulinotropic polypeptide, is a 42 amino acid intestinal hormone with effects on fat and glucose metabolism.
M53985	(Pro3) GIP, human	(Pro3) GIP, human ((Pro3) Gastric Inhibitory Peptide, human) is an efficacious, stable and specific human GIP receptor (hGIPR) full agonist.
M53852	GIP (3-42), human	GIP (3-42), human acts as a glucose-dependent insulinotropic polypeptide (GIP) receptor antagonist, moderating the insulin secreting and metabolic actions of GIP in vivo.
M50424	[pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153)	[pTyr1146][pTyr1150][pTyr1151]Insulin Receptor (1142-1153) binds to insulin and can be used as insulin receptor tyrosine kinase substrates.
M50423	GIP (1-30) amide, porcine	GIP (1-30) amide, porcine is a full glucose-dependent insulinotropic polypeptide (GIP) receptor agonist with high affinity equal to native GIP(1-42).
M50421	CMX-2043	CMX-2043 is a novel analogue of α-Lipoic Acid.
M50420	DA-JC4	DA-JC4 is a dual GLP-1/GIP receptor agonist and can be used for the research of neurological disease and insulin signaling pathways.
M50419	Acetyl Gastric Inhibitory Peptide (human)	Acetyl Gastric Inhibitory Peptide (human) is a fatty acid derivatized analog of glucose-dependent insulinotropic polypeptide with improved antihyperglycaemic and insulinotropic properties.
M50418	Gastric Inhibitory Polypeptide (1-30), porcine	Gastric Inhibitory Polypeptide (1-30), porcine lacks the C-terminal 12 amino acid residues of natural gastric inhibitory polypeptide (GIP), exhibits biologic activity by potentiating the release of insulin and somatostatin.
M50417	[Tyr0] Gastric Inhibitory Peptide (23-42), human	[Tyr0] Gastric Inhibitory Peptide (23-42), human, a glucose-dependent insulinotropic polypeptide (GIP), is a weak inhibitor of gastric acid secretion that also stimulates insulin secretion.
M50416	GIP (1-30) amide, human	GIP (1-30) amide,human is a glucose-dependent insulinotropic polypeptide (GIP) fragment.

By Signaling Pathways

By Product Type

Signaling Pathways

Insulin Receptor Insulin Receptor

Get to Know Us

Customer Support

Resources

Contact Us